Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle - PubMed (original) (raw)
Comparative Study
Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle
N Watanabe et al. EMBO J. 1995.
Abstract
In higher eukaryotes, the cyclin-dependent kinases (CDKs) are negatively regulated by phosphorylation on threonine 14 (T14) and tyrosine 15 (Y15). In fission yeast, the Wee1 and mitosis inhibitory kinase 1 (Mik1) protein kinases phosphorylate Y15 in Cdc2. WEE1Hu is the only known protein kinase that can carry out this inhibitory phosphorylation on Y15 in higher eukaryotes. In the present study, we examined the endogenous products of WEE1Hu in human cells and found that the original WEE1Hu cDNA lacked 214 amino acids at the N-terminus. The predicted full-length protein has weak, but significant, similarity over its entire length with Mik1. Thus, we suggest that 'WEE1Hu' is a Mik1-related protein rather than a Wee1 homologue. When isolated in immunoprecipitates, the endogenous WEE1Hu phosphorylated several cyclin-associated CDKs on Y15. WEE1Hu activity increased during S and G2 phases in parallel with the level of protein. Its activity decreased at M phase when WEE1Hu became transiently hyperphosphorylated. In addition, a decrease in WEE1Hu protein level was observed at M/G1 phase. Apparently, the hyperphosphorylation and degradation in combination caused inactivation of WEE1Hu at M phase and the following G1 phase. These results suggest that the activity of WEE1Hu is regulated by phosphorylation and proteolytic degradation, and that WEE1Hu plays a role in inhibiting mitosis before M phase by phosphorylating cyclin B1-Cdc2.
Similar articles
- The Wee1 protein kinase regulates T14 phosphorylation of fission yeast Cdc2.
Den Haese GJ, Walworth N, Carr AM, Gould KL. Den Haese GJ, et al. Mol Biol Cell. 1995 Apr;6(4):371-85. doi: 10.1091/mbc.6.4.371. Mol Biol Cell. 1995. PMID: 7626804 Free PMC article. - Two Distinct Cdc2 Pools Regulate Cell Cycle Progression and the DNA Damage Response in the Fission Yeast S.pombe.
Caspari T, Hilditch V. Caspari T, et al. PLoS One. 2015 Jul 1;10(7):e0130748. doi: 10.1371/journal.pone.0130748. eCollection 2015. PLoS One. 2015. PMID: 26131711 Free PMC article. - Regulation of Cdc2 activity by phosphorylation at T14/Y15.
Berry LD, Gould KL. Berry LD, et al. Prog Cell Cycle Res. 1996;2:99-105. doi: 10.1007/978-1-4615-5873-6_10. Prog Cell Cycle Res. 1996. PMID: 9552387 Review. - Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition.
Katayama K, Fujita N, Tsuruo T. Katayama K, et al. Mol Cell Biol. 2005 Jul;25(13):5725-37. doi: 10.1128/MCB.25.13.5725-5737.2005. Mol Cell Biol. 2005. PMID: 15964826 Free PMC article. - Mammalian G2 regulatory genes and their possible involvement in genetic instability in cancer cells.
Okayama H, Nagata A, Igarashi M, Suto K, Jinno S. Okayama H, et al. Princess Takamatsu Symp. 1991;22:231-8. Princess Takamatsu Symp. 1991. PMID: 1844245 Review.
Cited by
- Effect of Sortilin1 on promoting angiogenesis and systemic metastasis in hepatocellular carcinoma via the Notch signaling pathway and CD133.
Ahn HR, Kim S, Baek GO, Yoon MG, Kang M, Ng JT, Go Y, Lim SB, Yoon JH, Jeong JY, Han JE, Kim SS, Cheong JY, Eun JW, Cho HJ. Ahn HR, et al. Cell Death Dis. 2024 Aug 29;15(8):634. doi: 10.1038/s41419-024-07016-7. Cell Death Dis. 2024. PMID: 39209807 Free PMC article. - Crosstalk among WEE1 Kinase, AKT, and GSK3 in Nav1.2 Channelosome Regulation.
Singh AK, Singh J, Goode NA, Laezza F. Singh AK, et al. Int J Mol Sci. 2024 Jul 24;25(15):8069. doi: 10.3390/ijms25158069. Int J Mol Sci. 2024. PMID: 39125637 Free PMC article. - Oxidative stress mediates nucleocytoplasmic shuttling of KPNA2 via AKT1-CDK1 axis-regulated S62 phosphorylation.
Huang JX, Wang CI, Kuo CY, Chang TW, Liu YC, Hsiao TF, Wang CL, Yu CJ. Huang JX, et al. FASEB Bioadv. 2024 Jul 5;6(8):276-288. doi: 10.1096/fba.2024-00078. eCollection 2024 Aug. FASEB Bioadv. 2024. PMID: 39114447 Free PMC article. - Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group.
Stiegeler N, Garsed DW, Au-Yeung G, Bowtell DDL, Heinzelmann-Schwarz V, Zwimpfer TA. Stiegeler N, et al. Front Oncol. 2024 Jun 4;14:1387281. doi: 10.3389/fonc.2024.1387281. eCollection 2024. Front Oncol. 2024. PMID: 38894867 Free PMC article. Review. - Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations.
Fukuda K, Takeuchi S, Arai S, Nanjo S, Sato S, Kotani H, Kita K, Nishiyama A, Sakaguchi H, Ohtsubo K, Yano S. Fukuda K, et al. Cell Rep Med. 2024 Jun 18;5(6):101578. doi: 10.1016/j.xcrm.2024.101578. Epub 2024 May 21. Cell Rep Med. 2024. PMID: 38776912 Free PMC article.
References
- J Biol Chem. 1994 Dec 2;269(48):30530-7 - PubMed
- Science. 1992 Sep 18;257(5077):1689-94 - PubMed
- Cell. 1993 Mar 26;72(6):919-29 - PubMed
- Cell. 1992 Jul 10;70(1):139-51 - PubMed
- J Biol Chem. 1977 Feb 10;252(3):1102-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous